Leadership from the great northern Indian state of Uttar Pradesh, home to the Taj Mahal, has decided to approve the use of ivermectin as a treatment and prevention of COVID-19. The drug will be used instead of hydroxychloroquine. Moving forward, ivermectin will be allocated to frontline health professionals treating patients in hospitals serving COVID-19. Yet another positive data point for the use of ivermectin as one approach to fighting COVID-19. Will the Western press care?
As reported in DNA India and multiple times in TrialSite, ivermectin is being successfully used across India as one economical way to stem the onslaught of the pandemic. Hospitals and institutions from AIIMS, Lady Hardinge Medical College, and Max Hospital to Lok Nayak, now routinely administer ivermectin to COVID-19 patients. The Indian Express reports that the switch and acceptance of ivermectin came as the result of positive results from a study at Agra.
If press accounts are entirely accurate, the health department in Uttar Pradesh and elsewhere are prescribing the anti-parasitic drug, even to those who just come into contact with COVID-19 patients, in ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).